These drugs are both approved to treat high LDL-cholesterol levels in people with cardiovascular disease or primary hyperlipidemia, a genetic condition where cholesterol and other blood fats like triglycerides are too high
Currently, there's no FDA-approved oral tirzepatide
Clinical data supports that appetite changes can manifest as early as week one for some, while for others, this effect might take a month or even longer to become truly apparent
20.Lillys triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
O'Hare AM, Batten A, Burrows NR et al (2012) Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis
Common side effects of Mounjaro include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and stomach pain